Assignee
ONCTERNAL THERAPEUTICS INC
US·13 granted patents·4 pending applications·38 citations·filing 2016–2025
Top patents by PatentIndex Score
17 records- 0192US11285132B2Uses of indolinone compoundsONCTERNAL THERAPEUTICS INC·Filed 2020·Granted Mar 29, 2022·3 cites·8 claims
- 0292US9987251B2Indolinone compounds and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2016·Granted Jun 5, 2018·8 cites·18 claims
- 0391US9895352B2Indolinone compounds and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2016·Granted Feb 20, 2018·6 cites·16 claims
- 0490US12161626B2Uses of indolinone compoundsONCTERNAL THERAPEUTICS INC·Filed 2022·Granted Dec 10, 2024·1 cites·20 claims
- 0589US10646470B2Uses of indolinone compoundsONCTERNAL THERAPEUTICS INC·Filed 2018·Granted May 12, 2020·3 cites·8 claims
- 0688US11591290B2Selective androgen receptor degrader (SARD) ligands and methods of use thereofONCTERNAL THERAPEUTICS INC·Filed 2020·Granted Feb 28, 2023·2 cites·6 claims
- 0788US10159660B2Uses of indolinone compoundsONCTERNAL THERAPEUTICS INC·Filed 2017·Granted Dec 25, 2018·6 cites·8 claims
- 0886US9822122B2Indoline analogs and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2017·Granted Nov 21, 2017·4 cites·10 claims
- 0985US11084811B2Compounds for treatment of cancerONCTERNAL THERAPEUTICS INC·Filed 2019·Granted Aug 10, 2021·2 cites·11 claims
- 1082US10711008B2Indoline analogs and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2019·Granted Jul 14, 2020·1 cites·6 claims
- 1181US10351569B2Indoline analogs and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2017·Granted Jul 16, 2019·2 cites·13 claims
- 1280US2022288023A1Indolinone compounds and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1368US12187720B2Compounds for treatment of cancerONCTERNAL THERAPEUTICS INC·Filed 2021·Granted Jan 7, 2025·0 cites·16 claims
- 1465US2018256546A1Indolinone compounds and uses thereofONCTERNAL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1564US2026008849A1Antibody formulationsONCTERNAL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1655US11465987B2Compounds for treatment of cancerONCTERNAL THERAPEUTICS INC·Filed 2016·Granted Oct 11, 2022·0 cites·16 claims
- 1755US2023070988A1Combinations of egfr inhibitors and ror1 inhibitors for the treatment of cancerONCTERNAL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →